Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023
Tue, October 10, 2023
Mon, October 9, 2023

Michael Ulz Maintained (AKRO) at Buy with Decreased Target to $33 on, Oct 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-33-on-oct-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Ulz of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Buy with Decreased Target from $70 to $33 on, Oct 11th, 2023.

Michael has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $60 on, Wednesday, September 13th, 2023
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023

Publication Contributing Sources